Toon Van Gorp, MD, PhD, discussed findings from the MIRASOL trial and the potential of mirvetuximab to redefine treatment ...
12h
CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces the signing of a letter of intent (LOI) for the ...
Communiqué de la société OXURION du 18/03/2025 - Oxurion signs a letter of intent for the planned acquisition of a biometrics-focused CRO ...
The circuit consists of a total of 24 tournaments, with Events 5-8 taking place Saturday and today. The ladies can earn prize money with their results. These achievements count toward the Women's ...
Mirvetuximab soravtansine improved overall survival over chemotherapy in patients with FRα-positive, platinum-resistant ovarian cancer.
NORTH CHICAGO, IL, USA I March 15, 2025 I AbbVie (NYSE: ABBV) today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the ...
The Belgian capital is renowned across the world as the centre of European politics. There are over 2,250 international ...
This year’s edition, from 13 to 23 March, you can enjoy more than 45 events spread all over the city ... Whether you're a jazz aficionado or just looking for a great night out, Leuven Jazz welcomes ...
First-ever global no-alcohol beer partnership in WSL history will enhance moments of relaxation and celebration for athletes and fans LISBON, Portugal -- (BUSINESS WIRE) -- Today, Corona Cero, the ...
AbbVie (NYSE: ABBV) today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE� (mirvetuximab soravtansine-gynx) in women with folate ...
Dr. Jo Sourbron, MD, PhD, MPharm, is a physician scientist with a clinical practice at the University Hospitals of Ghent (UZ Ghent, Belgium) and a postdoctoral researcher at the University of Leuven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback